Franklin Resources Inc Ventyx Biosciences, Inc. Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.9 - $10.13 $33,350 - $177,811	17,553 New	17,553 $96,000
Q2 2023 Aug 11, 2023	SELL	$28.53 - $39.55 $8.09 Million - $11.2 Million	-283,572 Reduced 95.58%	13,119 $430,000
Q1 2023 May 12, 2023	BUY	$29.51 - $46.65 $8.76 Million - $13.8 Million	296,691 New	296,691 $9.94 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $128M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.